Form 4: Clover Health Insider Sells Shares for Tax Withholding

Clover Health Investments Corp. CEO Jamie L. Reynoso reported the disposition of 6,197 shares of Class A Common Stock to cover tax obligations upon the vesting of restricted stock units.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., reported a transaction on April 3, 2026.
• This transaction involved the automatic withholding of 6,197 shares of Class A Common Stock.
• The shares were withheld to cover tax obligations arising from the vesting of restricted stock units (RSUs).
• These RSUs were originally granted on January 3, 2023, and a portion vested on April 3, 2026.
• The remaining RSUs are scheduled to vest in equal quarterly installments, with the final vesting on January 3, 2027, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share disposition is a standard procedure for covering tax liabilities upon RSU vesting and does not necessarily indicate a change in the executive's investment outlook.

Negatives

• Insider selling, even for tax purposes, can sometimes be perceived negatively by the market.

Risks

• The continued service of the Reporting Person is a condition for the vesting of remaining RSUs, implying a risk of forfeiture if service is not maintained.

Future Outlook

The remaining restricted stock units are set to vest in equal quarterly installments, with the final vesting scheduled for January 3, 2027, provided the reporting person continues their service with the company.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to RSU vesting and tax withholding, are routine events for executives in the health insurance and technology sectors. These transactions often reflect standard compensation practices rather than a change in the executive's conviction about the company's prospects.

Stakeholder Impact

• Shareholders: The sale of shares by an insider, even for tax purposes, may be observed but is unlikely to have a significant direct impact on the stock price as it's a pre-planned event.

Next Steps

• Continued vesting of remaining RSUs in quarterly installments until January 3, 2027.
• Potential future tax withholding transactions upon subsequent RSU vesting dates.

Key Dates

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, Stock Vesting, Tax Withholding, RSU, Jamie L. Reynoso